Monte Rosa Therapeutics had a revenue of 23.19M in the quarter ending Jun 30, 2025, with -72.69%. This bring the company's revenue in the last twelve months to 177.99M, Decreased 11.60%. In the fiscal year ending Dec 31, 2024, Monte Rosa Therapeutics had annual revenue of 75.62M with Infinity% growth.